{"transactions":[{"id":1745759,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":1,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108423,"kind":"organization","name":"Omega Fund VI GP, L.P.","position":2,"cik":"0001826592","reported_name":"Omega Fund VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":3,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36727,"kind":"person","name":"Stampacchia Otello","position":4,"cik":"0001361712","reported_name":"Stampacchia Otello","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108425,"kind":"person","name":"Nessi Claudio","position":5,"cik":"0001722050","reported_name":"Nessi Claudio","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108426,"kind":"person","name":"Paster Anne-Mari","position":6,"cik":"0001652863","reported_name":"Paster Anne-Mari","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B convertible preferred stock","published_at":"2023-11-09T20:36:25.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":false,"shares":2615533,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":287213},"source":{"system":"sec-edgar","filing":"0001209191-23-054913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1722050/000120919123054913/doc4.xml","form_type":"4"}},{"id":1745758,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":1,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108423,"kind":"organization","name":"Omega Fund VI GP, L.P.","position":2,"cik":"0001826592","reported_name":"Omega Fund VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":3,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36727,"kind":"person","name":"Stampacchia Otello","position":4,"cik":"0001361712","reported_name":"Stampacchia Otello","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108425,"kind":"person","name":"Nessi Claudio","position":5,"cik":"0001722050","reported_name":"Nessi Claudio","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108426,"kind":"person","name":"Paster Anne-Mari","position":6,"cik":"0001652863","reported_name":"Paster Anne-Mari","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A convertible preferred stock","published_at":"2023-11-09T20:36:25.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":false,"shares":14999999,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1415865},"source":{"system":"sec-edgar","filing":"0001209191-23-054913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1722050/000120919123054913/doc4.xml","form_type":"4"}},{"id":1745757,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":1,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108423,"kind":"organization","name":"Omega Fund VI GP, L.P.","position":2,"cik":"0001826592","reported_name":"Omega Fund VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":3,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36727,"kind":"person","name":"Stampacchia Otello","position":4,"cik":"0001361712","reported_name":"Stampacchia Otello","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108425,"kind":"person","name":"Nessi Claudio","position":5,"cik":"0001722050","reported_name":"Nessi Claudio","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108426,"kind":"person","name":"Paster Anne-Mari","position":6,"cik":"0001652863","reported_name":"Paster Anne-Mari","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T20:36:25.000Z","date":"2023-11-07","kind":"purchase","planned":false,"acquired":true,"shares":454545,"price":11,"value":4999995.0,"ownership":{"direct":true},"balance_after":2157623,"source":{"system":"sec-edgar","filing":"0001209191-23-054913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1722050/000120919123054913/doc4.xml","form_type":"4"}},{"id":1745756,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":1,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108423,"kind":"organization","name":"Omega Fund VI GP, L.P.","position":2,"cik":"0001826592","reported_name":"Omega Fund VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":3,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36727,"kind":"person","name":"Stampacchia Otello","position":4,"cik":"0001361712","reported_name":"Stampacchia Otello","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108425,"kind":"person","name":"Nessi Claudio","position":5,"cik":"0001722050","reported_name":"Nessi Claudio","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108426,"kind":"person","name":"Paster Anne-Mari","position":6,"cik":"0001652863","reported_name":"Paster Anne-Mari","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T20:36:25.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":true,"shares":287213,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."}],"balance_after":1703078,"source":{"system":"sec-edgar","filing":"0001209191-23-054913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1722050/000120919123054913/doc4.xml","form_type":"4"}},{"id":1745755,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":1,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108423,"kind":"organization","name":"Omega Fund VI GP, L.P.","position":2,"cik":"0001826592","reported_name":"Omega Fund VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":3,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36727,"kind":"person","name":"Stampacchia Otello","position":4,"cik":"0001361712","reported_name":"Stampacchia Otello","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108425,"kind":"person","name":"Nessi Claudio","position":5,"cik":"0001722050","reported_name":"Nessi Claudio","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108426,"kind":"person","name":"Paster Anne-Mari","position":6,"cik":"0001652863","reported_name":"Paster Anne-Mari","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T20:36:25.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":true,"shares":1415865,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."}],"balance_after":1415865,"source":{"system":"sec-edgar","filing":"0001209191-23-054913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722050/000120919123054913/doc4.xml","form_type":"4"}},{"id":2542458,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":1,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":2,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":36727,"kind":"person","name":"Stampacchia Otello","position":3,"cik":"0001361712","reported_name":"Stampacchia Otello","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":108425,"kind":"person","name":"Nessi Claudio","position":4,"cik":"0001722050","reported_name":"Nessi Claudio","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":108426,"kind":"person","name":"Paster Anne-Mari","position":5,"cik":"0001652863","reported_name":"Paster Anne-Mari","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Series B Preferred Stock","published_at":"2021-10-14T16:40:04.000Z","date":"2021-10-12","kind":"exercise","acquired":false,"shares":693152,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Omega Fund VI, L.P. (\"Omega VI\") held 693,152 shares of the Issuer's Series B Preferred Stock. On October 12, 2021, the Series B Preferred Stock automatically converted into 523,979 shares of the Issuer's Common Stock on a 1-for-1.32286 reverse split basis, immediately prior to and in connection with the closing of a public offering of the Issuer's securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the \"Securities Act\") and without payment of further consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Omega Fund VI, L.P. (\"Omega VI\") held 693,152 shares of the Issuer's Series B Preferred Stock. On October 12, 2021, the Series B Preferred Stock automatically converted into 523,979 shares of the Issuer's Common Stock on a 1-for-1.32286 reverse split basis, immediately prior to and in connection with the closing of a public offering of the Issuer's securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the \"Securities Act\") and without payment of further consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Omega Fund VI, L.P. (\"Omega VI\") held 693,152 shares of the Issuer's Series B Preferred Stock. On October 12, 2021, the Series B Preferred Stock automatically converted into 523,979 shares of the Issuer's Common Stock on a 1-for-1.32286 reverse split basis, immediately prior to and in connection with the closing of a public offering of the Issuer's securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the \"Securities Act\") and without payment of further consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Omega Fund VI, L.P. (\"Omega VI\") held 693,152 shares of the Issuer's Series B Preferred Stock. On October 12, 2021, the Series B Preferred Stock automatically converted into 523,979 shares of the Issuer's Common Stock on a 1-for-1.32286 reverse split basis, immediately prior to and in connection with the closing of a public offering of the Issuer's securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the \"Securities Act\") and without payment of further consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are beneficially owned by Omega Fund VI, L.P. (\"Omega VI\"). The reported securities may be deemed to be beneficially owned by each of Omega Fund VI GP, L.P. (\"Omega VI GP\"), as the general partner of Omega VI, and Omega Fund VI GP Manager, Ltd. (\"Omega VI GP Manager\"), as the general partner of Omega VI GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega VI GP Manager and have shared voting and investment power over the shares held by Omega VI and, as a result, may each be deemed to beneficially own the reported securities. Each of such individuals disclaims beneficial ownership of the shares held by Omega VI."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"As of October 12, 2021 and after giving effect to the transactions reported above, Omega VI holds less than 10% of the outstanding shares of the Issuer's Common Stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":523979},"source":{"system":"sec-edgar","filing":"0000899243-21-040245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000089924321040245/doc4.xml","form_type":"4"}},{"id":2542457,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":1,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":2,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":36727,"kind":"person","name":"Stampacchia Otello","position":3,"cik":"0001361712","reported_name":"Stampacchia Otello","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":108425,"kind":"person","name":"Nessi Claudio","position":4,"cik":"0001722050","reported_name":"Nessi Claudio","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":108426,"kind":"person","name":"Paster Anne-Mari","position":5,"cik":"0001652863","reported_name":"Paster Anne-Mari","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2021-10-14T16:40:04.000Z","date":"2021-10-12","kind":"purchase","acquired":true,"shares":187500,"price":16,"value":3000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are beneficially owned by Omega Fund VI, L.P. (\"Omega VI\"). The reported securities may be deemed to be beneficially owned by each of Omega Fund VI GP, L.P. (\"Omega VI GP\"), as the general partner of Omega VI, and Omega Fund VI GP Manager, Ltd. (\"Omega VI GP Manager\"), as the general partner of Omega VI GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega VI GP Manager and have shared voting and investment power over the shares held by Omega VI and, as a result, may each be deemed to beneficially own the reported securities. Each of such individuals disclaims beneficial ownership of the shares held by Omega VI."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"As of October 12, 2021 and after giving effect to the transactions reported above, Omega VI holds less than 10% of the outstanding shares of the Issuer's Common Stock."}],"balance_after":711479,"source":{"system":"sec-edgar","filing":"0000899243-21-040245","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000089924321040245/doc4.xml","form_type":"4"}},{"id":2542456,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":1,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":2,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":36727,"kind":"person","name":"Stampacchia Otello","position":3,"cik":"0001361712","reported_name":"Stampacchia Otello","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":108425,"kind":"person","name":"Nessi Claudio","position":4,"cik":"0001722050","reported_name":"Nessi Claudio","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":108426,"kind":"person","name":"Paster Anne-Mari","position":5,"cik":"0001652863","reported_name":"Paster Anne-Mari","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2021-10-14T16:40:04.000Z","date":"2021-10-12","kind":"exercise","acquired":true,"shares":523979,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Omega Fund VI, L.P. (\"Omega VI\") held 693,152 shares of the Issuer's Series B Preferred Stock. On October 12, 2021, the Series B Preferred Stock automatically converted into 523,979 shares of the Issuer's Common Stock on a 1-for-1.32286 reverse split basis, immediately prior to and in connection with the closing of a public offering of the Issuer's securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the \"Securities Act\") and without payment of further consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are beneficially owned by Omega Fund VI, L.P. (\"Omega VI\"). The reported securities may be deemed to be beneficially owned by each of Omega Fund VI GP, L.P. (\"Omega VI GP\"), as the general partner of Omega VI, and Omega Fund VI GP Manager, Ltd. (\"Omega VI GP Manager\"), as the general partner of Omega VI GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega VI GP Manager and have shared voting and investment power over the shares held by Omega VI and, as a result, may each be deemed to beneficially own the reported securities. Each of such individuals disclaims beneficial ownership of the shares held by Omega VI."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"As of October 12, 2021 and after giving effect to the transactions reported above, Omega VI holds less than 10% of the outstanding shares of the Issuer's Common Stock."}],"balance_after":523979,"source":{"system":"sec-edgar","filing":"0000899243-21-040245","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000089924321040245/doc4.xml","form_type":"4"}},{"id":2908812,"issuer":{"id":143846,"kind":"organization","name":"Omega Alpha SPAC","symbol":"OMEG"},"owners":[{"id":143847,"kind":"organization","name":"Omega Alpha Management","position":1,"cik":"0001831897","reported_name":"Omega Alpha Management","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143848,"kind":"person","name":"Pearsall Alexandra","position":2,"cik":"0001838885","reported_name":"Pearsall Alexandra","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":3,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108423,"kind":"organization","name":"Omega Fund VI GP, L.P.","position":4,"cik":"0001826592","reported_name":"Omega Fund VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":5,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2021-01-13T16:15:32.000Z","date":"2021-01-11","kind":"purchase","acquired":true,"shares":501000,"price":10,"value":5010000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported Class A ordinary shares were purchased as Private Placement Shares by Omega Alpha Management for $10.00 per share, as described under the heading \"Description of Securities\" in the Issuer's registration statement on Form S-1 (File No. 333-251551)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Omega Alpha Management (the \"Sponsor\"). The Sponsor is governed by two managers, Otello Stampacchia, who is a director of Omega Fund VI GP Manager, Ltd. (\"Omega Top GP\"), which is the general partner of Omega Fund VI GP, L.P. (\"Omega GP\"), which is the general partner of Omega Fund VI, L.P. (\"Omega VI\"), the sole member of the Sponsor, and Alexandra Pearsall (together with Mr. Stampacchia, the \"Managers\"). As such, each of Omega Top GP, Omega GP, Omega VI and the Managers has voting and investment discretion with respect to the Class B Ordinary Shares held by the Sponsor and, as a result, each may be deemed to beneficially own the reported securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of the reporting persons (other than the Sponsor) disclaims Section 16 beneficial ownership of the shares except to the extent, if any, of its, his or her respective pecuniary interest therein, and this report shall not be deemed an admission that any of such person is the beneficial owner of such shares for Section 16 or any other purpose."}],"balance_after":501000,"source":{"system":"sec-edgar","filing":"0001104659-21-003864","document":"tm212973d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1832010/000110465921003864/tm212973d1_4seq1.xml","form_type":"4"}},{"id":3005316,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":1,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":2,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108423,"kind":"organization","name":"Omega Fund VI GP, L.P.","position":3,"cik":"0001826592","reported_name":"Omega Fund VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-10-16T16:15:26.000Z","date":"2020-10-14","kind":"exercise","acquired":false,"shares":12500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock automatically converted into 0.152881822351322 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on October 14, 2020 (on an adjusted basis, after giving effect to the 1-for-6.541 reverse stock split of the common stock effected by the Issuer on October 2, 2020) The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock automatically converted into 0.152881822351322 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on October 14, 2020 (on an adjusted basis, after giving effect to the 1-for-6.541 reverse stock split of the common stock effected by the Issuer on October 2, 2020) The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock automatically converted into 0.152881822351322 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on October 14, 2020 (on an adjusted basis, after giving effect to the 1-for-6.541 reverse stock split of the common stock effected by the Issuer on October 2, 2020) The shares have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of Series B Preferred Stock automatically converted into 0.152881822351322 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on October 14, 2020 (on an adjusted basis, after giving effect to the 1-for-6.541 reverse stock split of the common stock effected by the Issuer on October 2, 2020) The shares have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are beneficially owned by Omega Fund VI, L.P. (\"Omega VI\"). The reported securities may be deemed to be beneficially owned by each of Omega Fund VI GP, L.P. (\"Omega VI GP\"), as the general partner of Omega VI, and Omega Fund VI GP Manager, Ltd. (\"Omega VI GP Manager\"), as the general partner of Omega VI GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega VI GP Manager and have shared voting and investment power over the shares held by Omega VI and, as a result, may each be deemed to beneficially own the reported securities. Ms. Dina Chaya Moghrabi, a Director of the Issuer, is an advisor at Omega Fund Management, LLC, an entity affiliated with Omega VI. Each of such individuals, together with Omega VI GP and Omega VI GP Manager and Ms. Moghrabi, disclaims beneficial ownership of the shares held by Omega VI."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1911022},"source":{"system":"sec-edgar","filing":"0001209191-20-055014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919120055014/doc4.xml","form_type":"4"}},{"id":3005315,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":1,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":2,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108423,"kind":"organization","name":"Omega Fund VI GP, L.P.","position":3,"cik":"0001826592","reported_name":"Omega Fund VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T16:15:26.000Z","date":"2020-10-14","kind":"purchase","acquired":true,"shares":250000,"price":15,"value":3750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were purchased in the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are beneficially owned by Omega Fund VI, L.P. (\"Omega VI\"). The reported securities may be deemed to be beneficially owned by each of Omega Fund VI GP, L.P. (\"Omega VI GP\"), as the general partner of Omega VI, and Omega Fund VI GP Manager, Ltd. (\"Omega VI GP Manager\"), as the general partner of Omega VI GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega VI GP Manager and have shared voting and investment power over the shares held by Omega VI and, as a result, may each be deemed to beneficially own the reported securities. Ms. Dina Chaya Moghrabi, a Director of the Issuer, is an advisor at Omega Fund Management, LLC, an entity affiliated with Omega VI. Each of such individuals, together with Omega VI GP and Omega VI GP Manager and Ms. Moghrabi, disclaims beneficial ownership of the shares held by Omega VI."}],"balance_after":2161022,"source":{"system":"sec-edgar","filing":"0001209191-20-055014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919120055014/doc4.xml","form_type":"4"}},{"id":3005314,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":108422,"kind":"organization","name":"Omega Fund VI, L.P.","position":1,"cik":"0001757917","reported_name":"Omega Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":108424,"kind":"organization","name":"Omega Fund VI GP Manager, Ltd.","position":2,"cik":"0001826584","reported_name":"Omega Fund VI GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108423,"kind":"organization","name":"Omega Fund VI GP, L.P.","position":3,"cik":"0001826592","reported_name":"Omega Fund VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T16:15:26.000Z","date":"2020-10-14","kind":"exercise","acquired":true,"shares":1911022,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock automatically converted into 0.152881822351322 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on October 14, 2020 (on an adjusted basis, after giving effect to the 1-for-6.541 reverse stock split of the common stock effected by the Issuer on October 2, 2020) The shares have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are beneficially owned by Omega Fund VI, L.P. (\"Omega VI\"). The reported securities may be deemed to be beneficially owned by each of Omega Fund VI GP, L.P. (\"Omega VI GP\"), as the general partner of Omega VI, and Omega Fund VI GP Manager, Ltd. (\"Omega VI GP Manager\"), as the general partner of Omega VI GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega VI GP Manager and have shared voting and investment power over the shares held by Omega VI and, as a result, may each be deemed to beneficially own the reported securities. Ms. Dina Chaya Moghrabi, a Director of the Issuer, is an advisor at Omega Fund Management, LLC, an entity affiliated with Omega VI. Each of such individuals, together with Omega VI GP and Omega VI GP Manager and Ms. Moghrabi, disclaims beneficial ownership of the shares held by Omega VI."}],"balance_after":1911022,"source":{"system":"sec-edgar","filing":"0001209191-20-055014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919120055014/doc4.xml","form_type":"4"}}]}